>>> US After Hours Summary: BBBY +30.3%, KFRC +24.2%, SANM +13% higher on earnin

After Hours Summary: BBBY +30.3%, KFRC +24.2%, SANM +13% higher on earnings; RMBS -10.6%, NOV -8.1%, CLS -7.9% lower on earnings

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: BBBY +30.3%, KFRC +24.2%, LC +13.5%, SEI +13.3% (also signs third long-term contract with global technology company), SANM +13% (also approves $600 mln buyback program), SSD +5.6%, CDP +4%, NUE +3.7%, UHS +2.9%, TFII +2%, CR +1.6%, CDNS +1.3%, PSA +0.5%, ARE +0.3%, BRO +0.3%

Companies trading higher in after hours in reaction to news: ORKA +5.1% ($500 mln stock offering), BMEA +3.5% (52-week results from Phase 2 COVALENT-112 trial in type 1 diabetes), TSHA +2.2% (to present new preclinical data supporting construct design of TSHA-102 ), ACRS +2.1% (to provide clinical update on key biologic and oral inhibitor programs), PRTA +1.9% (FDA grants Fast Track Designation to coramitug), CRNX +1.6% (European Commission has approved Palsonify), HESM +1.4% (increases quarterly cash distribution), CABA +1.4% (announces multiple upcoming presentations), RITM +0.9% (commercial real estate platform Paramount Group has rebranded as Elecor Properties), AWK +0.8% ($500k infrastructure upgrade project), CACI +0.6% (achieves AWS managed service provider status), NVDA +0.4% (CAO to retire), EDIT +0.3% (to present new preclinical data demonstrating progress of EDIT-401), GH +0.3% (CMO to resign), ET +0.2% (increases dividend), EFC +0.2% (estimated book value per share of $13.56), TIGO +0.2% (acquires remaining 32.5% stake in Coltel), JANX +0.1% (to discontinue further clinical development of JANX008), VOR +0.1% (stock offering by selling shareholders)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: GABC -16.5%, RMBS -10.6%, NOV -8.1%, CLS -7.9%, RNGR -6%, HLMN -4.3%, AMKR -3.6%, VTR -1.5%, LTBR -0.7%, CINF -0.1%, CCK -0.1%

Companies trading lower in after hours in reaction to news: ERAS -34.5% (preliminary Phase 1 dose escalation data for pan-RAS molecular glue ERAS-0015), NTLA -2.5% ($150 mln share stock offering), BMM -2.2% (approved a final investment decision on the construction for its Nussir project), MANE -2.1% (stock offering), AXG -1.2% (MoU with SC Ventures), PACS -0.5% (CFO to retire; names successor), CSV -0.3% (files $350 mln mixed shelf offering), ORCL -0.2% (co, BorderPlex and Bloom Energy (BE) to power Project Jupiter), BAH -0.2% (names new CFO)